Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IRAK1 anticorps (pThr209)

L’anticorps Lapin Polyclonal anti-IRAK1 a été validé pour WB, FACS, IF (cc) et IHC (p). Il convient pour détecter IRAK1 dans des échantillons de Humain, Souris et Rat.
N° du produit ABIN742658

Aperçu rapide pour IRAK1 anticorps (pThr209) (ABIN742658)

Antigène

Voir toutes IRAK1 Anticorps
IRAK1 (Interleukin-1 Receptor-Associated Kinase 1 (IRAK1))

Reactivité

  • 149
  • 83
  • 63
  • 2
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 143
  • 14
  • 2
Lapin

Clonalité

  • 144
  • 15
Polyclonal

Conjugué

  • 60
  • 9
  • 7
  • 7
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp IRAK1 est non-conjugé

Application

  • 112
  • 67
  • 64
  • 52
  • 51
  • 24
  • 18
  • 15
  • 15
  • 12
  • 11
  • 4
  • 2
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Épitope

    • 31
    • 24
    • 17
    • 16
    • 11
    • 8
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr209

    Specificité

    This phosphorylation site is homologous to Thr209 in Mouse and Rat.

     Réactivité croisée

    Humain, Souris, Rat

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic phosphopeptide derived from human IRAK1 around the phosphorylation site of Thr209 [RG(p-T)HN]

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    FCM 1:20-100
    IHC-P 1:200-400
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

    Date de péremption

    12 months
  • Antigène

    IRAK1 (Interleukin-1 Receptor-Associated Kinase 1 (IRAK1))

    Autre désignation

    IRAK1

    Sujet

    Synonyms: IRAK, pelle, Interleukin-1 receptor-associated kinase 1, IRAK-1, IRAK1

    Background: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.

    ID gène

    3654

    UniProt

    P51617

    Pathways

    Signalisation NF-kappaB, Signalisation TLR, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Toll-Like Receptors Cascades
Vous êtes ici:
Chat with us!